Acute ischemic stroke patients with each PIRI score on 5-point scale

February 16, 2023 — According to an accepted manuscript published in ARRS’ American Journal of Roentgenology (AJR), percent insular ribbon infarction (PIRI) complements current stroke outcome predictors, classifying patients with slowly progressive stroke who could benefit from late-window endovascular thrombectomy (EVT).

Noting that PIRI was independently associated with infarct growth rate and 90-day outcome, “PIRI may help identify patients who could benefit from late-window EVT when requiring transfer to EVT-capable centers,” wrote head researcher Robert W. Regenhardt, MD, PhD, from the department of neurology at Massachusetts General Hospital and Harvard Medical School.

Analyzing a previous clinical trial of acute stroke patients untreated with reperfusion therapies from January 2007 to June 2009, Regenhardt et al. reevaluated 31 trial patients (median age, 71 years; 12 female, 19 male) with anterior-circulation large-vessel occlusion who underwent serial MRI examinations. Two neuroradiologists independently scored PIRI on presentation MRI—mild (0-1), moderate (2), severe (3-4)—based upon length ratios of the insula portion showing restricted diffusion to the insula’s total length. A 90-day modified Rankin Scale (mRS) was also obtained.

Ultimately, in multivariable models controlling for age, large-vessel occlusion location, and collateral pattern, PIRI category was a significant independent predictor of presentation-to-48-hour infarct growth rate (β=1.3) and 90-day mRS ≤2 (OR=0.2). Sensitivity and specificity for predicting 90-day mRS ≤2 were 90% and 84% for mild-to-moderate PIRI, versus 70% and 74% for symmetric collateral pattern.

“To our knowledge,” the authors of this AJR accepted manuscript added, “the present study is the first to show the PIRI category to be an independent predictor of 90-day mRS <2 in multivariable models.”

For more information: www.arrs.org


Related Content

News | Cardiac Imaging

May 20, 2025 — Royal Philips has launched the RADIQAL (Radiation Dose and Image Quality Trial) trial. This multicenter ...

Time May 27, 2025
arrow
News | Pediatric Imaging

May 13, 2025-- GE HealthCare recently announced the U.S. Food and Drug Administration (FDA) has approved a pediatric ...

Time May 20, 2025
arrow
News | Artificial Intelligence

April 16, 2025 — An artificial intelligence (AI) program trained to review images from a common medical test can detect ...

Time April 16, 2025
arrow
News | Pediatric Imaging

April 10, 2025 — Cincinnati Children’s and GE HealthCare will form a strategic research program focused on driving ...

Time April 10, 2025
arrow
News | Radiology Imaging

Jan. 15, 2025 — University of California, San Francisco (UCSF) Department of Radiology & Biomedical Imaging and GE ...

Time January 27, 2025
arrow
News | Contrast Media

Jan. 10, 2025 – Bayer has announced positive topline results of the Phase III QUANTI studies evaluating the efficacy and ...

Time January 14, 2025
arrow
News | Women's Health

Aug. 19, 2024 — GE HealthCare recently announced a collaboration with the University of California San Diego School of ...

Time August 29, 2024
arrow
News | PET-CT

July 31, 2024 — In a head-to-head comparison with FDG PET/CT, FDG PET/MRI demonstrated comparable or superior diagnostic ...

Time July 31, 2024
arrow
News | Radiology Business

July 25, 2024 — Immunis, Inc., a clinical-stage biotech developing groundbreaking secretome therapeutics for age and ...

Time July 25, 2024
arrow
News | PET-CT

July 25, 2024 — Positron Corporation, a leading molecular imaging medical device company offering PET & PET-CT imaging ...

Time July 25, 2024
arrow
Subscribe Now